Because endogenous IL-37 has powerful anti-inflammatory properties and significantly ameliorates intestinal inflammation in a mouse colitis model, the researchers hypothesized that the mechanism of action of IL-37 was likely intracellular; therefore, the exogenous administration of IL-37 could not perform the anti-inflammatory functions20. The gene discussed is IL37; the disease is colitis.